Analysts/Institutional Investor Meet/Con. Call Updates
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Remedium Lifecare Ltd has informed BSE about an investors meet scheduled for 25th April 2025 at 4:00 PM, to be held virtually via Zoom. The agenda of the meeting is the closing of the company's ongoing right issue. The company has clarified that the discussion will focus on the right issue and will not involve any unpublished price sensitive information (UPSI). The disclosure is filed under Regulation 30 of SEBI LODR Regulations, 2015. The filing is signed by Adarsh Munjal, Whole Time Director.
This is a routine regulatory disclosure and not material to the stock price, since the company has explicitly stated no UPSI will be shared. However, it signals that the company's right issue is in its closing stage, which may be of interest to existing shareholders and potential subscribers tracking the issue timeline.